Geron is executing in the clinic with success in IMerge, and other studies are set to read out in late 2023, 2024, and beyond. Find out why GERN stock is a Buy.

GERN reported total net revenue of $47.5M for Q4'24 with cost of goods sold of $783K for the quarter. GERN's net loss was $25.4M for Q4'24, with net cash used in operating activities of $218.6M in ...

Geron Corporation (NASDAQ:GERN) is one of the 13 Stocks Under $5 With High Upside Potential. Log In Sign Up Premium #1 AI Stock to Buy. ... Let’s face it, complacency breeds stagnation.

GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm. March 14, 2025 07:36 PM Eastern Daylight Time. LOS ANGELES--(BUSINESS WIRE) ...